dc.contributor.author | Ar, Muhlis Cem | |
dc.contributor.author | Soysal, Teoman | |
dc.contributor.author | Eskazan, AHMET EMRE | |
dc.date.accessioned | 2021-03-03T09:07:18Z | |
dc.date.available | 2021-03-03T09:07:18Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Soysal T., Eskazan A. E. , Ar M. C. , "Generics in chronic myeloid leukemia: Current arguments for and against and the established evidence", Expert Review of Hematology, cilt.7, sa.6, ss.697-699, 2014 | |
dc.identifier.issn | 1747-4086 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_1b4f2e2c-0452-455f-8c5a-c32a27faf9cc | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/23642 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84911425152&origin=inward | |
dc.identifier.uri | https://doi.org/10.1586/17474086.2014.966679 | |
dc.language.iso | eng | |
dc.title | Generics in chronic myeloid leukemia: Current arguments for and against and the established evidence | |
dc.type | Makale | |
dc.relation.journal | Expert Review of Hematology | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 7 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 697 | |
dc.identifier.endpage | 699 | |
dc.contributor.firstauthorID | 113125 | |